首页>
外国专利>
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
展开▼
机译：减少多发性硬化症患者中特氟米特和瑞舒伐他汀不良相互作用的风险的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention relates to a method for managing the risk of an adverse interaction between teriflunomide and a substrate of breast cancer resistance protein (BCRP) and/or organic anion transporting polypeptide B1 and B3 (OATP1B1/B3).
展开▼
